BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36860917)

  • 1. Oncogenic and Receptor-Mediated Wnt Signaling Influence the Sensitivity of Colonic Cells to Butyrate.
    Bordonaro M
    J Cancer; 2023; 14(3):446-453. PubMed ID: 36860917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.
    Lazarova D; Lee A; Wong T; Marian B; Chiaro C; Rainey C; Bordonaro M
    J Cancer; 2014; 5(3):203-13. PubMed ID: 24563675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
    Bordonaro M; Lazarova DL
    JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further analysis of p300 in mediating effects of Butyrate in Colorectal Cancer Cells.
    Bordonaro M
    J Cancer; 2020; 11(20):5861-5866. PubMed ID: 32922528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
    Lazarova DL; Bordonaro M
    J Cell Mol Med; 2016 Jun; 20(6):989-93. PubMed ID: 27072512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
    Bordonaro M; Lazarova DL
    World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
    Lazarova D; Bordonaro M
    J Cancer; 2017; 8(8):1453-1459. PubMed ID: 28638460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
    Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
    J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 Knockout Promotes Butyrate Resistance.
    Lazarova DL; Bordonaro M
    J Cancer; 2017; 8(17):3405-3409. PubMed ID: 29151923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells.
    Lazarova DL; Chiaro C; Bordonaro M
    BMC Res Notes; 2014 Apr; 7():226. PubMed ID: 24716727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
    Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
    J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlexanox and UPF1 Modulate Wnt Signaling and Apoptosis in HCT-116 Colorectal Cancer Cells.
    Bordonaro M; Lazarova D
    J Cancer; 2019; 10(2):287-292. PubMed ID: 30719122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
    Bordonaro M
    J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk?
    Bordonaro M; Lazarova DL; Sartorelli AC
    Cell Cycle; 2008 May; 7(9):1178-83. PubMed ID: 18418037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Wnt-specific colon cancer cell kill by butyrate and lithium.
    Bordonaro M; Lazarova DL; Carbone R; Sartorelli AC
    Oncol Res; 2004; 14(9):427-38. PubMed ID: 15490974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between Wnt Signaling and RNA Processing in Colorectal Cancer.
    Bordonaro M
    J Cancer; 2013; 4(2):96-103. PubMed ID: 23386908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells.
    Bordonaro M; Tewari S; Cicco CE; Atamna W; Lazarova DL
    PLoS One; 2011; 6(11):e27308. PubMed ID: 22073312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.